Human growth hormone‐induced mitotic maladaptation in podocytes and implications in diabetic kidney disease
Journal of Neuroendocrinology · 2026-02 · 38 (2)
DOI: 10.1111/jne.70122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 12.12.2025. Verfasst von Bharath Banoth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Hyderabad, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Human Growth Hormone, Mitosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research.
Abstract (Originalsprache)
Diabetes is a significant risk factor for the development of diabetic kidney disease, and about 30% of people with type I diabetes mellitus will eventually develop end‐stage kidney disease. Growth hormone (GH) and its mediator insulin‐like growth factor (IGF‐I) are crucial for kidney development and function in healthy conditions. However, elevated circulatory levels of GH in type I diabetes mellitus disrupt homeostasis and cause changes in the kidney's structure and function, such as hypertrophy, glomerulosclerosis, and proteinuria. Glomerular podocytes are specialized cells in the nephron, and they practically represent the kidney's filtration function. Podocytes are terminally differentiated cells, and podocyte injury or loss causes significant damage to the glomerulus manifested by varying degrees of proteinuria. Recent studies have identified that podocytes express GH receptors and are key targets of GH action, particularly in settings with type I diabetes mellitus. GH could negatively affect podocyte biology, thus potentially contributing to glomerular manifestations, kidney damage, and thereby contribute to diabetic kidney disease. GH evokes the reactivation of the embryologically active Notch signaling in adult podocytes. As a consequence, terminally differentiated podocytes undergo cell‐cycle reentry. This manuscript overviews the aberrant activation of embryologically active pathways in quiescent adult podocytes, complications of cell‐cycle reentry, aberrations in cytokinesis, and consequent mitosis‐associated cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Hyderabad, Hyderabad, Telangana, India.
ORCID-Profile: Anil Kumar Pasupulati
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Indian Council of Medical Research
Zitieren
APA
Banoth, B., Raviraj, S., & Pasupulati, A. K. (2026). Human growth hormone‐induced mitotic maladaptation in podocytes and implications in diabetic kidney disease. Journal of Neuroendocrinology, 38(2). https://doi.org/10.1111/jne.70122
Vancouver
Banoth B, Raviraj S, Pasupulati AK. Human growth hormone‐induced mitotic maladaptation in podocytes and implications in diabetic kidney disease. Journal of Neuroendocrinology. 2026;38(2). doi:10.1111/jne.70122
BibTeX
@article{Banoth2026,
author = {Banoth, Bharath and Raviraj, Sumathi and Pasupulati, Anil Kumar},
title = {Human growth hormone‐induced mitotic maladaptation in podocytes and implications in diabetic kidney disease},
journal = {Journal of Neuroendocrinology},
year = {2026},
volume = {38},
number = {2},
doi = {10.1111/jne.70122}
}
EUVIMED